Publication:
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

cris.virtualsource.author-orcida5541bd1-b9f4-4ca5-9876-de5d6a047370
datacite.rightsopen.access
dc.contributor.authorMach, François
dc.contributor.authorBaigent, Colin
dc.contributor.authorCatapano, Alberico L
dc.contributor.authorKoskinas, Konstantinos
dc.contributor.authorCasula, Manuela
dc.contributor.authorBadimon, Lina
dc.contributor.authorChapman, M John
dc.contributor.authorDe Backer, Guy G
dc.contributor.authorDelgado, Victoria
dc.contributor.authorFerence, Brian A
dc.contributor.authorGraham, Ian M
dc.contributor.authorHalliday, Alison
dc.contributor.authorLandmesser, Ulf
dc.contributor.authorMihaylova, Borislava
dc.contributor.authorPedersen, Terje R
dc.contributor.authorRiccardi, Gabriele
dc.contributor.authorRichter, Dimitrios J
dc.contributor.authorSabatine, Marc S
dc.contributor.authorTaskinen, Marja-Riitta
dc.contributor.authorTokgozoglu, Lale
dc.contributor.authorWiklund, Olov
dc.date.accessioned2024-09-02T16:18:24Z
dc.date.available2024-09-02T16:18:24Z
dc.date.issued2020-01-01
dc.description.numberOfPages78
dc.description.sponsorshipUniversitätsklinik für Kardiologie
dc.identifier.doi10.7892/boris.147206
dc.identifier.pmid31504418
dc.identifier.publisherDOI10.1093/eurheartj/ehz455
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/37454
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofEuropean heart journal
dc.relation.issn1522-9645
dc.relation.organizationDCD5A442BB15E17DE0405C82790C4DE2
dc.subjectGuidelines apolipoprotein B cholesterol dyslipidaemias familial hypercholesterolaemia high-density lipoproteins lipoprotein remnants lipoprotein(a) low-density lipoproteins total cardiovascular risk treatment (adherence) treatment (drugs) treatment (lifestyle) triglycerides very low-density lipoproteins
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.title2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage188
oaire.citation.issue1
oaire.citation.startPage111
oaire.citation.volume41
oairecerif.author.affiliationUniversitätsklinik für Kardiologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2020-11-04 12:52:57
unibe.description.ispublishedpub
unibe.eprints.legacyId147206
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
2019 ESC,EAS Guidelines for the management of dyslipidaemias.pdf
Size:
2.41 MB
Format:
Adobe Portable Document Format
License:
publisher
Content:
published

Collections